UNITEDHEALTH GROUP INCORPORATED (Delaware)
Here’s whether UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.17% over 10 days). Concerns: RSI 94 — overbought, elevated pullback risk; weak 1-year return of -44.5%. Currently 45.4% off its 52-week high. Score: +2/7.
UNH is in a confirmed uptrend, trading above both its 50-day ($286.33) and 200-day ($312.62) moving averages. With an RSI of 94.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -44.5% compares to +35.1% for SPY (trailed the market by 79.6%). The current 45.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.